Cabbacis Inc. operates as a development stage tobacco product manufacturer and plant biotechnology company. The company is developing cigarettes with blends of tobacco that contains 90-95% less nicotine; and zero-THC/low-THC cannabis under the iBlend brand name. It holds a range of issued patents and pending patent applications pertaining to novel cigarettes and pods for oral electronic vaporizers across the United States, Europe, China, and internationally. The company was incorporated in 2023 and is based in Niagara Falls, New York.